CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a cost-effective, thermostable vaccine that protects against rabies and yellow fever. The vaccine will utilize innovative DNA technology for easy production and administration, targeting improved vaccination rates.
Rabies is the deadliest disease on earth (99.9% fatality rate).
Annually, ~58.000 people die from rabies, more than half of them are children.
Many remain unvaccinated because of the high costs and the need for a cold-chain.
Likewise, despite the existence of an excellent yellow fever (YF) vaccine, yearly ~30.000 people die of YF.
The 80-year old low-tech production process does not allow to produce sufficient doses.
There is now a real danger that major YF-outbreaks become uncontrollable.
We ai…
KATHOLIEKE UNIVERSITEIT LEUVEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, LONDON
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
